Biocartis has announced the launch of two new products on its molecular diagnostics platform Idyllaâ„¢. The Idyllaâ„¢ ctBRAF Mutation Assay uses blood plasma as a sample, which is far less invasive to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results